Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Redhill Biopharma Ltd (NASDAQ:RDHL)

8.44
Delayed Data
As of 3:59pm ET
 +0.23 / +2.80%
Today’s Change
8.10
Today|||52-Week Range
22.22
-34.47%
Year-to-Date
No recent news for Redhill Biopharma Ltd.

Today’s Trading

Previous close8.21
Today’s open8.23
Day’s range8.23 - 8.62
Volume17,927
Average volume (3 months)31,993
Market cap$104.4M
Dividend yield--
Data as of 3:59pm ET, 02/09/2016

Growth & Valuation

Earnings growth (last year)+30.60%
Earnings growth (this year)-39.04%
Earnings growth (next 5 years)--
Revenue growth (last year)+57,366.26%
P/E ratio--
Price/Sales16.81
Price/Book2.86

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc-0.02-1.21%
PETXAratana Therapeutics...-0.28-9.46%
MDGNMedgenics Inc-0.03-0.93%
----
Data as of 4:01pm ET, 02/09/2016

Financials

Next reporting dateFebruary 25, 2016
EPS forecast (this quarter)-$0.44
Annual revenue (last year)$6.9M
Annual profit (last year)-$10.6M
Net profit margin-152.71%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Dror Ben-Asher
Deputy CEO- Finance &
Operations
Ori Shilo
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers